Abstract
New psychoactive substances (NPS) have emerged in a threatening way in the last decades. They are sold via the internet or head shops with several names (bath salts, Research chemical, RCs, Legal Highs) and forms (pills, tablets, powder...etc.), and are labelled ambiguously to escape governmental legislation. Designer drugs belong to different chemical classes, but cathinones derivatives presented the most prevalent group. In 2013, this group accounted for 30% of NPS seizures in Europe with more than 450 different compounds, including 101 new molecules reported for the first time in 2014. The increased number of NPS as being sold in parallel market has led several countries to adopt different strategies either on individual surveillance of new emerging drugs or more efficiently on generic control regrouping a wide number of isomers and structurally similar compounds. The identification of these substances is a challenge for toxicologists, which requires sensitive and specific analytical methods based on LC-MS/MS or GC-MS. The usefulness of hair as an alternative matrix for prevalence studies was proved since it offers an overview on drug exposure with a large detection window over weeks or even months and years according to the length of the hair strand. However, as for many drugs of abuse, prevalence studies on cathinones derivatives use are still scarce. Self-reported use or case reports provide most of the available data.
The aim of this paper is to provide an update review on prevalence and surveillance of synthetic cathinones use conducted by hair analysis, excluding case report.
Keywords: New psychoactive substances, designer drugs, bath salts, hair, alternative biological matrix, prevalence, mass spectrometry, synthetic cathinones.
Current Pharmaceutical Design
Title:Prevalence and Surveillance of Synthetic Cathinones Use by Hair Analysis: An Update Review
Volume: 23 Issue: 36
Author(s): Jean-Claude Alvarez*, Nicolas Fabresse and Islam A. Larabi
Affiliation:
- Department of Pharmacology and Toxicology, Versailles Saint-Quentin-en-Yvelines University, Inserm U-1173, Raymond Poincare hospital, AP-HP, Garches,France
Keywords: New psychoactive substances, designer drugs, bath salts, hair, alternative biological matrix, prevalence, mass spectrometry, synthetic cathinones.
Abstract: New psychoactive substances (NPS) have emerged in a threatening way in the last decades. They are sold via the internet or head shops with several names (bath salts, Research chemical, RCs, Legal Highs) and forms (pills, tablets, powder...etc.), and are labelled ambiguously to escape governmental legislation. Designer drugs belong to different chemical classes, but cathinones derivatives presented the most prevalent group. In 2013, this group accounted for 30% of NPS seizures in Europe with more than 450 different compounds, including 101 new molecules reported for the first time in 2014. The increased number of NPS as being sold in parallel market has led several countries to adopt different strategies either on individual surveillance of new emerging drugs or more efficiently on generic control regrouping a wide number of isomers and structurally similar compounds. The identification of these substances is a challenge for toxicologists, which requires sensitive and specific analytical methods based on LC-MS/MS or GC-MS. The usefulness of hair as an alternative matrix for prevalence studies was proved since it offers an overview on drug exposure with a large detection window over weeks or even months and years according to the length of the hair strand. However, as for many drugs of abuse, prevalence studies on cathinones derivatives use are still scarce. Self-reported use or case reports provide most of the available data.
The aim of this paper is to provide an update review on prevalence and surveillance of synthetic cathinones use conducted by hair analysis, excluding case report.
Export Options
About this article
Cite this article as:
Alvarez Jean-Claude*, Fabresse Nicolas and Larabi A. Islam , Prevalence and Surveillance of Synthetic Cathinones Use by Hair Analysis: An Update Review, Current Pharmaceutical Design 2017; 23 (36) . https://dx.doi.org/10.2174/1381612823666170704124156
DOI https://dx.doi.org/10.2174/1381612823666170704124156 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunotherapy for Conformational Diseases
Current Pharmaceutical Design Genetic Algorithm and Self-Organizing Maps for QSPR Study of Some N-aryl Derivatives as Butyrylcholinesterase Inhibitors
Current Drug Discovery Technologies Current Pharmacological Approach to Restore Endothelial Dysfunction
Cardiovascular & Hematological Agents in Medicinal Chemistry A Comprehensive Review on the Ethnopharmacology, Phytochemistry, Pharmacology, and Toxicology of the Mandragora Genus; from Folk Medicine to Modern Medicine
Current Pharmaceutical Design Aerobic Exercise for Preventing Osteoporosis in Postmenopausal Women: an Update of its Effect on Bone Mineral Density
Current Rheumatology Reviews Nanoparticles for Colorectal Cancer Targeted Drug Delivery and MR Imaging: Current Situation and Perspectives
Current Cancer Drug Targets Clinical Trajectories and Biological Features of Primary Progressive Aphasia (PPA)
Current Alzheimer Research Probiotics and Oral Health
Current Pharmaceutical Design Microvascular Function/Dysfunction Downstream a Coronary Stenosis
Current Pharmaceutical Design Early Life and Oxidative Stress in Psychiatric Disorders: What Can we Learn From Animal Models?
Current Pharmaceutical Design GABA<sub>B</sub> Agonists for the Treatment of Alcohol Use Disorder
Current Pharmaceutical Design Effects of Opiates and HIV Proteins on Neurons: The Role of Ferritin Heavy Chain and a Potential for Synergism
Current HIV Research Subject Index to Volume 4
Current Drug Targets - Cardiovascular & Hematological Disorders A Dual Targeting Drug Delivery System for Penetrating Blood-Brain Barrier and Selectively Delivering siRNA to Neurons for Alzheimer’s Disease Treatment
Current Pharmaceutical Biotechnology Human Peroxiredoxins 1 and 2 and Their Interacting Protein Partners; Through Structure Toward Functions of Biological Complexes
Protein & Peptide Letters Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Current Diabetes Reviews Relevance of Excitable Media Theory and Retinal Spreading Depression Experiments in Preclinical Pharmacological Research
Current Neuropharmacology Phenolic Compounds, Antioxidant Properties and Enzyme Inhibition Ability of Adiantum capillus veneris L. linked to Alzheimer’s Disease, Diabetes Mellitus and Skin Disorders
Current Organic Chemistry Translational Challenge Models in Support of Efficacy Studies: Neurobehavioral and Cognitive Changes Induced by Transcranial Magnetic Stimulation in Healthy Volunteers
CNS & Neurological Disorders - Drug Targets Establishment of Method for the Determination of Aggregated α-Synuclein in DLB Patient Using RT-QuIC Assay
Protein & Peptide Letters